GB0018031D0 - Improvements relating to vaccines containing bordetella pertussis antigen - Google Patents

Improvements relating to vaccines containing bordetella pertussis antigen

Info

Publication number
GB0018031D0
GB0018031D0 GBGB0018031.5A GB0018031A GB0018031D0 GB 0018031 D0 GB0018031 D0 GB 0018031D0 GB 0018031 A GB0018031 A GB 0018031A GB 0018031 D0 GB0018031 D0 GB 0018031D0
Authority
GB
United Kingdom
Prior art keywords
improvements relating
bordetella pertussis
vaccines containing
pertussis antigen
containing bordetella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0018031.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbiological Research Authority
Original Assignee
Microbiological Research Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbiological Research Authority filed Critical Microbiological Research Authority
Priority to GBGB0018031.5A priority Critical patent/GB0018031D0/en
Publication of GB0018031D0 publication Critical patent/GB0018031D0/en
Priority to PCT/GB2001/003273 priority patent/WO2002007764A1/en
Priority to AU2001270894A priority patent/AU2001270894A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0018031.5A 2000-07-21 2000-07-21 Improvements relating to vaccines containing bordetella pertussis antigen Ceased GB0018031D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0018031.5A GB0018031D0 (en) 2000-07-21 2000-07-21 Improvements relating to vaccines containing bordetella pertussis antigen
PCT/GB2001/003273 WO2002007764A1 (en) 2000-07-21 2001-07-20 Improvements relating to vaccines containing bordetella pertussis antigen
AU2001270894A AU2001270894A1 (en) 2000-07-21 2001-07-20 Improvements relating to vaccines containing bordetella pertussis antigen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0018031.5A GB0018031D0 (en) 2000-07-21 2000-07-21 Improvements relating to vaccines containing bordetella pertussis antigen

Publications (1)

Publication Number Publication Date
GB0018031D0 true GB0018031D0 (en) 2000-09-13

Family

ID=9896159

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0018031.5A Ceased GB0018031D0 (en) 2000-07-21 2000-07-21 Improvements relating to vaccines containing bordetella pertussis antigen

Country Status (3)

Country Link
AU (1) AU2001270894A1 (en)
GB (1) GB0018031D0 (en)
WO (1) WO2002007764A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2597832T3 (en) 2013-03-08 2017-01-23 Janssen Vaccines & Prevention B.V. Acellular vaccine against pertussis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713156D0 (en) * 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines

Also Published As

Publication number Publication date
WO2002007764A1 (en) 2002-01-31
AU2001270894A1 (en) 2002-02-05

Similar Documents

Publication Publication Date Title
IL153506A0 (en) Multivalent vaccine composition
HUP0302117A3 (en) Vaccine composition
GB0020089D0 (en) Vaccine Composition
GB0023008D0 (en) Improvements in vaccination
HUP0204250A3 (en) Use of hiv-protein or -polynucleotide for vaccine produce
HUP0301092A3 (en) Vaccine
AU4433702A (en) Vaccines
AU4835001A (en) Antibodies to human cd154
HK1030166A1 (en) Adjuvants for use in vaccines
IL151942A0 (en) Compositions and methods for enhancing immunogenicity of antigens
HK1056884A1 (en) Purification of hbv antigens for use in vaccines
AU7013501A (en) Methods and composition for oral vaccination
PT1265633E (en) Adjuvant for vaccines
AU1591402A (en) Vaccine
GB0014288D0 (en) Vaccine
GB0018031D0 (en) Improvements relating to vaccines containing bordetella pertussis antigen
GB0026334D0 (en) Vaccine
GB0014845D0 (en) Vaccine
AU7112401A (en) Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
AU1493802A (en) Method for obtaining antigenic structures enhancing specific cross reactivity
GB0025694D0 (en) Vaccine
GB0015722D0 (en) Vaccine
GB0005728D0 (en) Conserved antigens
GB0015935D0 (en) Vaccine
GB0016686D0 (en) Novel vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)